Roche Oncology Event

Basel, 19 June 2006

Roche’s Investor and Analyst Briefing

Roche Oncology Event

The Roche Oncology Event was held on 19 June 2006 near Zurich, Switzerland.

Programme and presentations:

11.00 Setting new standards of cancer care PDF
Bill Burns, CEO Division Roche Pharmaceuticals
11.10 Roche strategy to develop cancer medicines PDF
Eduard E. Holdener, Head of Global Pharma Development
11.25 External speaker PDF
Peter Harper, Consultant Physician and Medical Oncologist at Guy's St. Thomas Hospital, London, UK
11.45 Roche setting the standards of cancer care PDF
Kapil Dhingra, Vice President, Medical Science
12.15 Q&A
12.25 Lunch
13.10 Latest update on Roche Oncology portfolio
Herceptin: Bart Vanhauwere Lifecycle Leader PDF
Tarceva: Don Maclean Lifecycle Leader PDF
Xeloda: Jonathan Dickinson Lifecycle Leader PDF
MabThera: David Loew Lifecycle Leader PDF
Avastin: Stefan Frings Deputy Lifecycle Leader PDF
14.15 Q&A
14.25 First workshop session:
Marketing a cancer drug PDF
Pascal Soriot, Director of Pharma Business & Strategic Marketing
Developing a cancer drug PDF
Kapil Dhingra, Vice President, Medical Science
Diagnostics and Biomarker development PDF
Joachim Eberle, Head of R&D, Roche Centralized Diagnostics
15.10 Repeated workshop session
(please find presentation files above in 1st workshop session)
16.00 Roche early development pipeline in Oncology PDF
Eduard E. Holdener, Head of Global Pharma Development
16.15 Bill Burns - Closing remarks
Venue: Giardino Verde
In der Rüti 2
8142 Uitikon
Zürich / Switzerland
Phone: +41-44-495-74-74
Fax: +41-44-495-74-70
www.giardinoverde.ch